Alexander Fleming, discoverer of penicillin, stated that he didn't plan to revolutionise all medicine by discovering the world's first antibiotic, but he did.
Crude mortality rates for all causes, non infectious causes and infectious diseases over the period 1900 - 1996.
Resistance to penicillin was foreseen early, with the concern that ignorant individuals may easily under dose themselves and make their microbes resistant.
Antibiotic target site is a crucial aspect of antimicrobial therapy.
Discovery of penicillin revolutionised treatment of infectious disease, increased life expectancy due to ability to prevent and treat infection.
Combination therapy is used for synergistic effects between two drugs, polymicrobial infections, and to avoid antagonistic effects.
Bacteriocidal antibiotics are able to kill or lyse bacterial cell, while bacterial multiplication does not resume even when the antibiotic is removed.
There are four main mechanisms of action: inhibition of cell wall synthesis, inhibition of protein synthesis, inhibition of DNA replication/synthesis, and inhibition of folate synthesis.
Antibiotics are substances produced by organisms that have inhibitory effects on other organisms, while synthetic drugs are produced in a lab.
Broad Spectrum Antibiotics include agents which are active against many Gram-positive and Gram-negative bacteria, while Narrow Spectrum Antibiotics act on certain types of bacteria only.
Narrow spectrum antibiotics act on certain types of bacteria only, with some exceptions.
Bacteriostatic antibacterials inhibit the growth of bacteria, while bactericidal antibacterials kill bacteria.
Concentration-dependent antibiotics, such as aminoglycosides and fluoroquinolones, have a peak concentration/minimum inhibitory concentration (C max /MIC) ratio and/or the area under the concentration-time curve at 24 h/MIC (AUC 0 - 24 /MIC) ratio that correlates with efficacy.
Peaks & Troughs refer to the serum antibacterial levels for drugs with a narrow therapeutic index, too high a level can lead to drug toxicity, while too low a level can lead to therapeutic range.
Antimicrobial susceptibility testing uses standardized criteria, such as CLSI and EUCAST, for MIC determination.
Researchers have had to implement continuous surveillance activities for resistance patterns due to the mutations in bacterial DNA.
On a larger scale, AST aids in the evaluation of treatment services provided by hospitals, clinics, and national programs for the control and prevention of infectious diseases.
Antimicbial stewardship evaluate the clinical response to treatment.
Inappropriate and/or delayed appropriate antibiotic use in the ICU has been shown to have an impact on morbidity and mortality.
Antibacterials are substances that inhibit the growth of or kill bacteria or other microorganisms, including bacteria, viruses, fungi, and protozoa.
Antimicrobial susceptibility testing (AST) is a laboratory procedure performed by medical technologists (clinical laboratory scientists) to identify which antimicrobial regimen is specifically effective for individual patients.
Use a narrow-spectrum antibiotic whenever possible, appropriate empirical choice for nosocomial sepsis, requires initial broad-spectrum antibiotics, even a combination, until culture and AST results are back and de-escalation should be implemented.
Pharmacodynamics is the study of the interaction between a drug and the body, including the effects of concentration at the site or exposure time for the drug, duration of use, and the effects of concentrated dosing.
Time-dependent antibiotics, such as beta-lactams, including penicillins and penems, glycopeptides, linezolid, macrolides, etc., have a peak concentration/minimum inhibitory concentration (C max /MIC) ratio that correlates with efficacy.
Penicillin hypersensitivity occurs in 0.4 - 10% of patients and can lead to mild rash or severe anaphylaxis and death.
Rare adverse effects of penicillins include haemolysis and nephritis.
Cephalosporins are good alternatives to penicillins when a broad-spectrum drug is required and should not be used as first choice unless the organism is known to be sensitive.
Second generation cephalosporins include cefaclor and cefuroxime and are active against enterobacteriaceae such as E. coli, Klebsiella spp, Proteus spp.
Ampicillin is less active than benzylpenicillin against Gram-positive bacteria but has a wider spectrum including Enterococcus faecalis, Haemophilus influenzae and some Escherichia coli, Klebsiella and Proteus strains.
Phenoxymethylpenicillin (Penicillin V) is acid stable and is given orally for minor infections.
Amoxycillin is similar but better absorbed orally and is sometimes combined with clavulanic acid, which binds strongly to β-lactamase and blocks the action of β-lactamase in this way.
Cephalosporins are produced from a fungus Cephalosporium acremonium.
Cephalosporins are bactericidal and modify cell wall synthesis, interfering at the final step of peptidoglycan synthesis (Transpeptidation).
First generation cephalosporins include cefadroxil, cefalexin, cefadrine and are most active against Gram-positive cocci.
Fourth generation cephalosporins include cefpirome and are better against Gram-positive than third generation.
Cephalosporins are classified into first, second, third, and fourth generations.
Third generation cephalosporins include cefixime and other IV cefotaxime, ceftriaxone, ceftazidime.
Diarrhoea is common with ampicillin, less common with amoxycillin.
Ampicillin is acid stable, is given orally or parenterally, but is β-lactamase sensitive.
Cephalosporins owe their activity to a β-lactam ring and are bactericidal.